187 results
Page 4 of 10
424B3
0hyo5 4xq7rj5
11 May 21
Prospectus supplement
5:19pm
8-K
EX-99.2
8769tpkb l3
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-99.2
c2j104uy iuxyvbv
29 Mar 21
Business combination disclosure
7:27am
8-K
bsxjgkq
28 Jan 21
Cost Associated with Exit or Disposal Activities
8:01am
8-K
EX-99.1
xok3 h5ki
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
EX-99.2
topxuz45rlp8q8y6xn
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
83eu ixs8ov8g1y
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
EX-99.2
iuei7gv7uinrtn 1wr
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
EX-99.1
sao on4p9x2hr6t3ew
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am